We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+1.67%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.32B
AUM Growth
-$225M
Cap. Flow
-$252M
Cap. Flow %
-5.84%
Top 10 Hldgs %
17.65%
Holding
636
New
71
Increased
161
Reduced
277
Closed
32

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$54.7M
2
CFG icon
Citizens Financial Group
CFG
+$21M
3
SBUX icon
Starbucks
SBUX
+$16.3M
4
AMZN icon
Amazon
AMZN
+$16.2M
5
THS
Treehouse Foods
THS
+$13.9M

Sector Composition

Rank Sector Weight
1 Healthcare 16.57%
2 Industrials 15.29%
3 Technology 15.12%
4 Financials 14.47%
5 Consumer Discretionary 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPHS
26
DELISTED
Innophos Holdings, Inc.
IPHS
$43.8M 1.02%
1,090,307
+105,965
+11% +$4.64M
OFIX icon
27
Orthofix Medical
OFIX
$481M
$39.1M 0.9%
664,644
-16,238
-2% -$910K
FNB icon
28
FNB Corp
FNB
$6.71B
$37.1M 0.86%
2,757,737
-132,816
-5% -$1.89M
TMO icon
29
Thermo Fisher Scientific
TMO
$208B
$35.2M 0.82%
170,477
-11,748
-6% -$2.47M
RTN
30
DELISTED
Raytheon Company
RTN
$35.1M 0.81%
162,701
-14,347
-8% -$2.97M
CXO
31
DELISTED
CONCHO RESOURCES INC.
CXO
$34.8M 0.81%
231,486
-24,276
-9% -$3.7M
ARMK icon
32
Aramark
ARMK
$15.2B
$34.5M 0.8%
1,207,570
-133,562
-10% -$4.09M
HCSG icon
33
Healthcare Services Group
HCSG
$1.58B
$33.9M 0.78%
779,349
-7,342
-0.9% -$359K
DHR icon
34
Danaher
DHR
$138B
$32.3M 0.75%
372,661
-6,750
-2% -$590K
SLB icon
35
SLB Ltd
SLB
$76.5B
$31.6M 0.73%
487,199
-5,281
-1% -$369K
SPXC icon
36
SPX Corp
SPXC
$11B
$30.9M 0.72%
952,085
-139,971
-13% -$4.43M
BMS
37
DELISTED
Bemis
BMS
$30.9M 0.71%
709,279
+133,759
+23% +$6.1M
UMPQ
38
DELISTED
Umpqua Holdings Corp
UMPQ
$30.5M 0.71%
1,426,750
+31,118
+2% +$680K
BCPC
39
Balchem Corp
BCPC
$5.29B
$30.4M 0.7%
371,654
-7,748
-2% -$610K
NTRS icon
40
Northern Trust
NTRS
$22.4B
$30.1M 0.7%
292,157
-8,377
-3% -$876K
PEP icon
41
PepsiCo
PEP
$191B
$29.9M 0.69%
273,822
+13,868
+5% +$1.58M
MMM icon
42
3M
MMM
$91.9B
$29.3M 0.68%
159,630
-850
-0.5% -$168K
AVY icon
43
Avery Dennison
AVY
$12.5B
$29.3M 0.68%
275,609
-26,173
-9% -$3.03M
GLD icon
44
SPDR Gold Trust
GLD
$132B
$26.4M 0.61%
210,109
+2,648
+1% +$334K
PFE icon
45
Pfizer
PFE
$141B
$26M 0.6%
771,247
-5,827
-0.7% -$200K
BAX icon
46
Baxter International
BAX
$12.1B
$25.9M 0.6%
398,484
-23,036
-5% -$1.56M
AIG icon
47
American International
AIG
$42B
$25M 0.58%
459,807
-53,341
-10% -$3.15M
TJX icon
48
TJX Companies
TJX
$173B
$23.8M 0.55%
582,822
-68,042
-10% -$2.69M
APH icon
49
Amphenol
APH
$184B
$23.7M 0.55%
1,099,620
-154,092
-12% -$3.47M
ICUI icon
50
ICU Medical
ICUI
$4.04B
$21.8M 0.5%
86,347
-10,749
-11% -$2.53M

Similar funds

Segall Bryant & Hamill's Q1 2018 Portfolio in Review

As of Q1 2018, Segall Bryant & Hamill held 636 positions worth $4.32B, down 4.9% from $4.54B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Segall Bryant & Hamill withdrew a net $252M in Q1 2018, closing 32 positions and reducing 277 holdings. Its most notable exit was Buffalo Wild Wings, Inc., an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

Against the trend, Segall Bryant & Hamill opened a new position in Labcorp worth $9.85M.

  • Segall Bryant & Hamill's largest Q1 2018 buy was Labcorp: 70,898 shares worth $9.85M.
  • Segall Bryant & Hamill added most to Mohawk Industries in Q1 2018, an estimated $22.1M increase.
  • Segall Bryant & Hamill's biggest Q1 2018 reduction was Hologic, cutting an estimated $54.7M.
  • Segall Bryant & Hamill fully exited Buffalo Wild Wings, Inc. in Q1 2018, selling an estimated $13.2M.
  • Segall Bryant & Hamill's ten largest holdings make up 18% of its $4.32B portfolio in Q1 2018.
  • Segall Bryant & Hamill opened 71 new positions and closed 32 in Q1 2018.
  • Segall Bryant & Hamill's portfolio value fell 4.9% quarter-over-quarter to $4.32B.

Based on Segall Bryant & Hamill's 13F filing for Q1 2018, filed 16 May 2018.